Omandam, Domingo P.

HRN: 24-31-84  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/05/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
01/05/2024
01/11/2024
IVT
1.5g
Q8
Balanitis;t/c Soft Tissue Infection
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: